v.231201
Showing details for project SYSMHC00043
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SYSMHC00043_0014T |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0017N |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0025T |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0026N |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0224T |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0230T |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0232N |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0237T |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0239N |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0267N |
6 |
Human |
|
|
HLA-A02:01 |
SYSMHC00043_0267T |
6 |
Human |
|
|
HLA-A02:01 |
Detailed view of sample SYSMHC00043_0026N
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
SYSMHC00043 |
SYSMHC00043_0026N |
FL0185_MON_0026N_even.raw |
Human |
In vitro |
Breast |
Breast cell |
adherent |
Breast carcinoma |
|
class I |
HLA-A02:01 |
29786170 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
Ultimate 3000 RSLCnano system |
no |
DDA |
HCD |
|
|
|
1 |
SYSMHC00043 |
SYSMHC00043_0026N |
FL0185_MON_0026N_odd.raw |
Human |
In vitro |
Breast |
Breast cell |
adherent |
Breast carcinoma |
|
class I |
HLA-A02:01 |
29786170 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
Ultimate 3000 RSLCnano system |
no |
DDA |
HCD |
|
|
|
2 |
SYSMHC00043 |
SYSMHC00043_0026N |
FL0185b_MON_0026N_even.raw |
Human |
In vitro |
Breast |
Breast cell |
adherent |
Breast carcinoma |
|
class I |
HLA-A02:01 |
29786170 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
Ultimate 3000 RSLCnano system |
no |
DDA |
HCD |
|
|
|
3 |
SYSMHC00043 |
SYSMHC00043_0026N |
FL0185b_MON_0026N_odd.raw |
Human |
In vitro |
Breast |
Breast cell |
adherent |
Breast carcinoma |
|
class I |
HLA-A02:01 |
29786170 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
Ultimate 3000 RSLCnano system |
no |
DDA |
HCD |
|
|
|
4 |
SYSMHC00043 |
SYSMHC00043_0026N |
FL0185c_MON_0026N_even_1h.raw |
Human |
In vitro |
Breast |
Breast cell |
adherent |
Breast carcinoma |
|
class I |
HLA-A02:01 |
29786170 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
Ultimate 3000 RSLCnano system |
no |
DDA |
HCD |
|
|
|
5 |
SYSMHC00043 |
SYSMHC00043_0026N |
FL0185c_MON_0026N_odd_1h.raw |
Human |
In vitro |
Breast |
Breast cell |
adherent |
Breast carcinoma |
|
class I |
HLA-A02:01 |
29786170 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
Ultimate 3000 RSLCnano system |
no |
DDA |
HCD |
|
|
|
6 |